MedTrace Logo

Patient Preference With Visicol Tablet Preparation for Colonoscopy

NCT00318305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2009-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonoscopy. This study will provide answers related to the patient preferences and their acceptance of this new method of bowel preparation.

Conditions

  • Preparation for Colonoscopy

Sponsors & Collaborators

  • InKine Pharmaceutical

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Suryakanth R. Gurudu, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00318305 on ClinicalTrials.gov